VAS
ALXN

Vestmark Advisory Solutions’s Alexion Pharmaceuticals ALXN Stock Holding History

Vestmark Advisory Solutions’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-7,142
Closed -$1.12M – 759
2020
Q4 		$1.12M Buy
7,142
+405
+6% +$52K 0.13% 223
2020
Q3 		$771K Buy
6,737
+624
+10% +$67.3K 0.1% 256
2020
Q2 		$686K Buy
6,113
+733
+14% +$77.8K 0.11% 250
2020
Q1 		$483K Buy
+5,380
New +$528K 0.09% 275
2019
Q4 		– Sell
-5,424
Closed -$531K – 544
2019
Q3 		$531K Buy
5,424
+2,018
+59% +$227K 0.09% 288
2019
Q2 		$446K Buy
3,406
+164
+5% +$21.1K 0.08% 305
2019
Q1 		$438K Buy
+3,242
New +$403K 0.08% 307

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $7.94B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $4.65B AUM 56.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return